The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2017

Filed:

Aug. 28, 2013
Applicant:

Fischer Medical Technologies, Llc, Broomfield, CO (US);

Inventors:

Ronald B. Shores, Greenwood Village, CO (US);

Morgan Nields, Englewood, CO (US);

David E. Gustafson, Westminster, CO (US);

Michael Tesic, Superior, CO (US);

Assignee:

FISCHER IMAGING, INC., Cumming, GA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 19/00 (2006.01); A61B 6/00 (2006.01); A61B 6/03 (2006.01); A61B 6/04 (2006.01); A61B 90/00 (2016.01);
U.S. Cl.
CPC ...
A61B 6/502 (2013.01); A61B 6/032 (2013.01); A61B 6/0435 (2013.01); A61B 6/4452 (2013.01); A61B 6/466 (2013.01); A61B 6/4021 (2013.01); A61B 6/482 (2013.01); A61B 2090/364 (2016.02);
Abstract

A prone CT breast x-ray imaging system is described that can image a full breast to create a conventional two-dimensional digital image in very high resolution (e.g., ≦25 micron pixels). The system is capable of imaging the entire breast in three-dimensional based on multiple projection views from a one-dimensional or two-dimensional detector. Data can be acquired and reconstructed with a limited number of views from limited angles or with conventional cone beam CT algorithms. The resulting three-dimensional image enables the detection and diagnosis of fine micro calcifications and small masses as may be distributed throughout the breast, thus allowing radiologists to make an improved determination of malignancy as opposed to conventional two-dimensional digital mammography. In addition, the injection of intravenous contrast in conjunction with or without pre and post contrast subtraction imaging provides a radiologist with morphologic information on the existing tumor burden in the breast. This capability may obviate the need for an independent contrast MRI exam of the breast which is increasingly performed for local staging and determination of tumor extent in a patient with a known cancer. Integrated biopsy capability permits convenient and rapid biopsy of any area suspicious for malignancy.


Find Patent Forward Citations

Loading…